News

In the first quarter of 2025, 29.7 million transactions were made in the Latvian Medicines Verification System (LZVS), which is slightly more than in the corresponding period of 2024.

Representatives of Arvato Customer Group countries met with system developer Arvato Systems GmbH in Vienna, Austria, on 25 and 26 March to plan further improvements in the National Medicines Verification System.

On November 22, 2021, a General Assembly of the Latvian Medicines Verification Organisation (LZVO) was held, where the strategy and budget for 2022 were approved, as well as a report on the most significant work done this year was presented.

In order for patients to receive only safe medicines, pharmacies and health care institutions in the first nine months of 2021 have checked in the verification system and handed over 19 million packages of medicines to residents in Latvia.

Inese Erdmane, Chairwoman of the Board at LZVO share insights of the Latvian medicine’s verification process with Dansk Medicin Verifikation Organisation Newsletter.

To guarantee the safety and authenticity of medicines to patients, in the first half of 2021, 12 million packages of medicines were verified in the system and reached consumers in Latvia, according to the Latvian Medicines Verification Organization (LZVO) data